NCT01634217View on ClinicalTrials.gov

Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

November 8, 2013

Primary Completion Date

December 1, 2017

Study Completion Date

December 1, 2018

Conditions
Acute Myelogenous LeukemiaAcute Lymphocytic LeukemiaChronic Myelogenous LeukemiaNon-Hodgkin LymphomaHodgkin LymphomaChronic Lymphocytic LeukemiaMultiple MyelomaMyelodysplastic Syndrome
Interventions
BIOLOGICAL

iTreg

The iTregs will be infused at the assigned dose without a filter or pump slowly by gravity over 15-60 minutes. The iTregs should be given at least 4 hours before the peripheral blood stem cell (PBSC) infusion (MT2001-10).

Trial Locations (1)

55455

Masonic Cancer Center, University of Minnesota, Minneapolis

All Listed Sponsors
lead

Masonic Cancer Center, University of Minnesota

OTHER

NCT01634217 - Inducible Regulatory T Cells (iTregs) in Non-Myeloablative Sibling Donor Peripheral Blood Stem Cell Transplantation | Biotech Hunter | Biotech Hunter